Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabien Zoulim

Showing results (61-70 of 499) with videos related to

Pageof 50
Sort By:
Current Opinion in HIV and AIDS|March 27, 2020
Direct-acting antivirals and viral RNA targeting for hepatitis B cureJanine French, Stephen Locarnini, Fabien Zoulim
Current Opinion in Investigational Drugs (London, England : 2000)|March 3, 2007
Glucosidase inhibitors as antiviral agents for hepatitis B and CDavid Durantel, Christine Alotte, Fabien Zoulim
Expert Review of Anti-Infective Therapy|April 7, 2009
Pathobiology of HBV mutants and clinical impact for treatment monitoringSi Nafa Si Ahmed, Fabien Zoulim
Presse Medicale (Paris, France : 1983)|January 28, 2017
[Hepatitis delta: Clinical aspects and therapeutic perspectives]Dulce Alfaiate, Clothilde Miaglia, Fabien Zoulim
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 1, 2008
Management of patients with decompensated hepatitis B virus associated [corrected] cirrhosisFabien Zoulim, Sylvie Radenne, Christian Ducerf
Liver International : Official Journal of the International Association for the Study of the Liver|January 5, 2017
Novel targets for hepatitis B virus therapyBarbara Testoni, David Durantel, Fabien Zoulim
Methods in Molecular Medicine|February 6, 2004
Study of HBV replication capacity in relation to sequence variation in the precore and core promoter regionsFabien Zoulim, ShuPing Tong, Christian Trépo
Egastroenterology|February 13, 2025
Opportunities and challenges for hepatitis B cureArmando Andres Roca Suarez, Fabien Zoulim
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 23, 2013
Kinetics of intrahepatic covalently closed circular DNA and serum hepatitis B surface antigen during antiviral therapy for chronic hepatitis B: lessons from experimental and clinical studiesFabien Zoulim, Barbara Testoni, Fanny Lebossé
Virologie (Montrouge, France)|October 28, 2020
[Management of Hepatitis B Virus (HBV) in transplantation]Clothilde Miaglia, Fanny Lebossé, Fabien Zoulim
Pageof 50

Showing results (61-70 of 499) with videos related to

Sort By:
Pageof 50
Current Opinion in HIV and AIDS|March 27, 2020
Direct-acting antivirals and viral RNA targeting for hepatitis B cureJanine French, Stephen Locarnini, Fabien Zoulim
Current Opinion in Investigational Drugs (London, England : 2000)|March 3, 2007
Glucosidase inhibitors as antiviral agents for hepatitis B and CDavid Durantel, Christine Alotte, Fabien Zoulim
Expert Review of Anti-Infective Therapy|April 7, 2009
Pathobiology of HBV mutants and clinical impact for treatment monitoringSi Nafa Si Ahmed, Fabien Zoulim
Presse Medicale (Paris, France : 1983)|January 28, 2017
[Hepatitis delta: Clinical aspects and therapeutic perspectives]Dulce Alfaiate, Clothilde Miaglia, Fabien Zoulim
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 1, 2008
Management of patients with decompensated hepatitis B virus associated [corrected] cirrhosisFabien Zoulim, Sylvie Radenne, Christian Ducerf
Liver International : Official Journal of the International Association for the Study of the Liver|January 5, 2017
Novel targets for hepatitis B virus therapyBarbara Testoni, David Durantel, Fabien Zoulim
Methods in Molecular Medicine|February 6, 2004
Study of HBV replication capacity in relation to sequence variation in the precore and core promoter regionsFabien Zoulim, ShuPing Tong, Christian Trépo
Egastroenterology|February 13, 2025
Opportunities and challenges for hepatitis B cureArmando Andres Roca Suarez, Fabien Zoulim
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 23, 2013
Kinetics of intrahepatic covalently closed circular DNA and serum hepatitis B surface antigen during antiviral therapy for chronic hepatitis B: lessons from experimental and clinical studiesFabien Zoulim, Barbara Testoni, Fanny Lebossé
Virologie (Montrouge, France)|October 28, 2020
[Management of Hepatitis B Virus (HBV) in transplantation]Clothilde Miaglia, Fanny Lebossé, Fabien Zoulim
Pageof 50